TargetMDD: Validating microRNA-186-5p as a molecular target for early intervention in Major Depressive Disorder

Ente: WT

Scadenza: 2028-04-01

Importo max: 686.327 €

Paese: EU

Descrizione

This project aims to validate a novel therapeutic strategy for Major Depressive Disorder (MDD) by targeting miR-186-5p, a microRNA elevated by chronic stress and linked to synaptic dysfunction in the prefrontal cortex. Targeting this upstream, stress-responsive microRNA offers a distinct approach co

Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.